지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Objectives: The aim of this study is to review and analyze the trends in prospective clinical research (PCR), project, clinical study protocol of Korean medicine (KM) for dementia.
Methods: We searched PCRs of KM on dementia in six electronical databases, up to January 28, 2021. Moreover, the clinical research protocol and projects of KM for dementia were searched.
Results: Total eight PCRs, nine projects, and three clinical study protocols were included. In the PCRs, there were one randomized controlled trial, five before and after study, and two comparative group before-after studies. Four of them used herbal medicine, two used acupuncture, one study used both herbal medicine and acupuncture, and the other one used moxibustion. Jowiseungchung-tang was the most frequently used herbal medicine. BL62, KI6 were used in electro-acupuncture, auricular-Shenmen in auricular acupuncture, and GV20 in moxibustion. The most frequent outcome was Korean-Dementia Rating Scale (K-DRS). One reported significant increase in K-DRS score, one reported 60% improvement, and the other studies mostly reported no significant difference. In the projects including 20 clinical studies of dementia, herbal medicine, integrative medicine and acupuncture were mainly used. In the protocols, herbal medicine, complex KM intervention, and integrative medicine were used.
Conclusions: Currently, the number of PCRs of KM for dementia is very scarce. Therefore, the researcher"s interest in this field and national research support should be made more, and the quality of clinical research in the future can be further improved by supplementing the limitations of previously published clinical research.
Methods: We searched PCRs of KM on dementia in six electronical databases, up to January 28, 2021. Moreover, the clinical research protocol and projects of KM for dementia were searched.
Results: Total eight PCRs, nine projects, and three clinical study protocols were included. In the PCRs, there were one randomized controlled trial, five before and after study, and two comparative group before-after studies. Four of them used herbal medicine, two used acupuncture, one study used both herbal medicine and acupuncture, and the other one used moxibustion. Jowiseungchung-tang was the most frequently used herbal medicine. BL62, KI6 were used in electro-acupuncture, auricular-Shenmen in auricular acupuncture, and GV20 in moxibustion. The most frequent outcome was Korean-Dementia Rating Scale (K-DRS). One reported significant increase in K-DRS score, one reported 60% improvement, and the other studies mostly reported no significant difference. In the projects including 20 clinical studies of dementia, herbal medicine, integrative medicine and acupuncture were mainly used. In the protocols, herbal medicine, complex KM intervention, and integrative medicine were used.
Conclusions: Currently, the number of PCRs of KM for dementia is very scarce. Therefore, the researcher"s interest in this field and national research support should be made more, and the quality of clinical research in the future can be further improved by supplementing the limitations of previously published clinical research.
목차
서론
방법
결과
고찰
결론
참고문헌
참고문헌 (23)
참고문헌 신청
Adrian Cheng / 2021 / A systematic review of the associations, mediators and moderators of life satisfaction, positive affect and happiness in near-centenarians and centenarians / Aging & Mental Health :1~17
Kim, K. W. / Korean dementia observatory 2016
René J.F. Melis / 2019 / Understanding and predicting the longitudinal course of dementia / Current Opinion in Psychiatry 32(2):123~129
Shaji, K. S. / 2018 / Clinical Practice Guidelines for Management of Dementia / Indian Journal of Psychiatry 60(Suppl 3):S312~S328
Jeffrey L Cummings / 2014 / Alzheimer’s disease drug-development pipeline: few candidates, frequent failures / Alzheimer's Research & Therapy 6(4):37
Kim, K. W. / Korean dementia observatory 2016
René J.F. Melis / 2019 / Understanding and predicting the longitudinal course of dementia / Current Opinion in Psychiatry 32(2):123~129
Shaji, K. S. / 2018 / Clinical Practice Guidelines for Management of Dementia / Indian Journal of Psychiatry 60(Suppl 3):S312~S328
Jeffrey L Cummings / 2014 / Alzheimer’s disease drug-development pipeline: few candidates, frequent failures / Alzheimer's Research & Therapy 6(4):37
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
혈관성 치매에 대한 근거기반 의한 협진 매뉴얼 제안
대한한의학회지
2019 .03
-
청소년기 우울증의 한약치료에 관한 주제범위 문헌고찰
대한한방소아과학회지
2022 .05
-
뇌성마비 아동의 한의치료 양상 분석
대한한의학회지
2019 .03
-
한약에 대한 N-of-1 임상시험의 현황 – 문헌 고찰
대한한의학회지
2020 .03
-
치매 및 우울증 고위험군 116례의 한의 치료에 대한 관찰 연구
동의생리병리학회지
2021 .06
-
온라인 포털에서 한약재 검색 트렌드와 의미에 대한 고찰
대한본초학회지(본초분과학회지)
2016 .01
-
식도암 한의 임상진료지침 개발 예비 연구
대한암한의학회지
2017 .01
-
코로나-19 무증상 감염 환자의 한약 치료 방안에 대한 고찰
대한한의학회지
2021 .03
-
비급여를 포함한 한의 외래의료이용의 최근(2008-2013) 변화추이
대한예방한의학회지
2017 .01
-
폐경 여성의 비만에 응용되는 한방치료에 대한 문헌 고찰
한방비만학회지
2019 .01
-
한약을 사용한 암환자 대상 임상시험에서의 항암 효능 평가변수 고찰
대한예방한의학회지
2024 .04
-
일본 건강보험의 한약 급여제도 현황
대한예방한의학회지
2022 .04
-
코로나-19 환자의 후유증 한약 치료에 대한 고찰
대한한방내과학회지
2021 .01
-
A Study on the Effectiveness of Herbal Medicine Treatment for 755 Traffic Accident Patients : A Retrospective Review According to the Type of Herbal Medicine Prescription
대한한의학회지
2018 .12
-
크론병의 한약 치료에 대한 최근 국내외 임상연구 동향
대한한방소아과학회지
2021 .11
-
Analysis of the Result of Korean Medicine Treatment for Female Subfertility Using Herbal Medicine, Acupuncture and Moxibustion Treatment
대한한의학회지
2015 .06
-
군진의학에서의 침치료 활용을 위한 연구동향 고찰
한방재활의학과학회지
2016 .01
-
우수한약재 생산을 위한 표준재배·가공 기준 확립의 중요성
한약정보연구회지
2019 .01
-
교통사고 후 한의치료에 대한 만족도 조사 연구
대한예방한의학회지
2021 .12
-
한의 암 증상 완화에 대한 한의사 대상 설문 조사
대한암한의학회지
2017 .01
이 논문의 저자 정보
이 논문과 함께 이용한 논문
알츠하이머 치매환자 분류 방법 비교 분석
이재경
,
서진범
,
이재성
외 1명
한국컴퓨터정보학회 학술발표논문집
2022
.07
알츠하이머 치매 환자에서 치료 전 중증도에 따른 약물의 장기 치료 효과
서희원
,
박유리
,
권인선
외 1명
생물치료정신의학
2021
.02
치매 단계별 일상생활수행능력의 차이 비교
장종식
한국산학기술학회 논문지
2017
.12
MRI 이미지 기반의 알츠하이머 치매분류 알고리즘
이재경
,
서진범
,
조영복
한국정보통신학회 종합학술대회 논문집
2021
.10
치매환자 100만 명 시대, 치료제 개발 어디까지? : 흔들리는 아밀로이드 베타 가설, 국내 연구진 치매의 새로운 원인 제시
장래혁
브레인
2020
.12
최근 본 자료
댓글(0)
0